ATE315645T1 - Dns oder gene, die an der parkinsonschen krankheit beteiligt sind - Google Patents
Dns oder gene, die an der parkinsonschen krankheit beteiligt sindInfo
- Publication number
- ATE315645T1 ATE315645T1 AT99902859T AT99902859T ATE315645T1 AT E315645 T1 ATE315645 T1 AT E315645T1 AT 99902859 T AT99902859 T AT 99902859T AT 99902859 T AT99902859 T AT 99902859T AT E315645 T1 ATE315645 T1 AT E315645T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- parkinson
- dna
- genes involved
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2753198 | 1998-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE315645T1 true ATE315645T1 (de) | 2006-02-15 |
Family
ID=12223704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99902859T ATE315645T1 (de) | 1998-02-09 | 1999-02-09 | Dns oder gene, die an der parkinsonschen krankheit beteiligt sind |
Country Status (10)
Country | Link |
---|---|
US (2) | US6716621B1 (de) |
EP (1) | EP1063294B1 (de) |
JP (1) | JP4430815B2 (de) |
AT (1) | ATE315645T1 (de) |
AU (1) | AU2299999A (de) |
CA (1) | CA2320220C (de) |
DE (2) | DE1063294T1 (de) |
DK (1) | DK1063294T3 (de) |
ES (1) | ES2257029T3 (de) |
WO (1) | WO1999040191A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775984B1 (fr) * | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
AU2299999A (en) * | 1998-02-09 | 1999-08-23 | Yoshikuni Mizuno | Dnas or genes participating in parkinson's disease |
DE69941300D1 (de) * | 1998-11-19 | 2009-10-01 | Aventis Pharma Sa | Fahren und verwendungen |
CA2996759A1 (fr) | 1998-11-19 | 2000-06-02 | Aventis Pharma S.A. | Mutations du gene de la parkine, compositions, methodes et utilisations |
EP1081225A1 (de) * | 1999-08-30 | 2001-03-07 | Biofrontera Pharmaceuticals GmbH | Transgenes Tiermodel für neurodegenerative Erkrankungen |
AU2001234171A1 (en) * | 2000-02-24 | 2001-09-03 | Boehringer Ingelheim International G.M.B.H | Parkin protein as ubiquitin ligase |
EP2319864A3 (de) * | 2000-03-22 | 2012-11-21 | Sanofi-Aventis Deutschland GmbH | Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinson's disease, use and method |
US7070940B2 (en) * | 2002-07-18 | 2006-07-04 | Aventis Pharma S.A. | Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein |
US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
US20080014194A1 (en) | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
US8697082B2 (en) | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US7358331B2 (en) | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
US7674599B2 (en) | 2003-11-08 | 2010-03-09 | Elan Pharmaceuticals, Inc. | Methods of using antibodies to detect alpha-synuclein in fluid samples |
WO2008095126A2 (en) | 2007-01-31 | 2008-08-07 | Elan Pharma International Limited | Assays for modulators of parkin activity using novel substrates |
US8147833B2 (en) | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
JP5558834B2 (ja) | 2007-02-23 | 2014-07-23 | ヤンセン アルツハイマー イミュノセラピー | シヌクレイノパチーおよびアミロイド形成疾患(amyloidogenicdisease)の予防および処置 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2299999A (en) * | 1998-02-09 | 1999-08-23 | Yoshikuni Mizuno | Dnas or genes participating in parkinson's disease |
-
1999
- 1999-02-09 AU AU22999/99A patent/AU2299999A/en not_active Abandoned
- 1999-02-09 ES ES99902859T patent/ES2257029T3/es not_active Expired - Lifetime
- 1999-02-09 AT AT99902859T patent/ATE315645T1/de active
- 1999-02-09 US US09/601,844 patent/US6716621B1/en not_active Expired - Fee Related
- 1999-02-09 WO PCT/JP1999/000545 patent/WO1999040191A1/ja active IP Right Grant
- 1999-02-09 DE DE1063294T patent/DE1063294T1/de active Pending
- 1999-02-09 CA CA2320220A patent/CA2320220C/en not_active Expired - Fee Related
- 1999-02-09 JP JP2000530605A patent/JP4430815B2/ja not_active Expired - Fee Related
- 1999-02-09 DK DK99902859T patent/DK1063294T3/da active
- 1999-02-09 DE DE69929417T patent/DE69929417T2/de not_active Expired - Lifetime
- 1999-02-09 EP EP99902859A patent/EP1063294B1/de not_active Expired - Lifetime
-
2004
- 2004-02-12 US US10/776,604 patent/US20050003385A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999040191A1 (fr) | 1999-08-12 |
ES2257029T3 (es) | 2006-07-16 |
EP1063294A1 (de) | 2000-12-27 |
US20050003385A1 (en) | 2005-01-06 |
DE69929417T2 (de) | 2006-08-03 |
US6716621B1 (en) | 2004-04-06 |
EP1063294B1 (de) | 2006-01-11 |
AU2299999A (en) | 1999-08-23 |
DK1063294T3 (da) | 2006-05-22 |
DE69929417D1 (de) | 2006-04-06 |
EP1063294A4 (de) | 2002-01-16 |
CA2320220C (en) | 2011-08-02 |
DE1063294T1 (de) | 2003-06-26 |
CA2320220A1 (en) | 1999-08-12 |
JP4430815B2 (ja) | 2010-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE315645T1 (de) | Dns oder gene, die an der parkinsonschen krankheit beteiligt sind | |
DK1013661T3 (da) | 2'-O,4'-metylen bicyklonukleosid | |
ES2066760T3 (es) | Nucleotidos de alquinilamino. | |
DE69840748D1 (de) | Verfahren zur zubereitung von antisense oligonukleotiden | |
ATE277068T1 (de) | 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind | |
ATE374836T1 (de) | Massenmarkierte hybridisierungssonden | |
DE69719220D1 (de) | Neue nucleotidanaloga | |
DE69825253D1 (de) | Verfahren für die herstellung von 1,1,1,3,3-pentafluorpropen und 2-chlor-pentafluorpropen | |
BR9912951A (pt) | Método de fabricação de nucleotìdoes de 1,3-oxatiolano | |
ATE342911T1 (de) | Synthese von nukleosiden und polynukleotiden | |
BR9908753B1 (pt) | processo de hidroconversão integrado. | |
ATE193733T1 (de) | Stahl für die herstellung von teilbaren maschinenteilen und maschinenteile, hergestellt aus diesen stahl | |
WO2001000661A3 (en) | Carnitine carrier related protein-1 | |
DE69816059D1 (de) | Gen, das für das pyruvat dehydrogenase kinase von pflanzen kodiert | |
WO2000015785A3 (de) | GENVERÄNDERUNG IM GEN FÜR DIE Gβ3-UNTEREINHEIT DES HUMANEN G-PROTEINS | |
ATE401403T1 (de) | Nukleotidsequenzen, die an erhöhung oder verringerung von der ovulationsgeschwindigkeit in säugertieren beteiligt sind | |
DE69402201D1 (de) | Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen | |
NO995858D0 (no) | Ny klasse kationiske nukleinsyre-overföringsmidler | |
DE59809600D1 (de) | Doppelmetallcyanid-katalysatoren für die herstellung von polyetherpolyolen | |
ATE270331T1 (de) | Rezeptor und dafür kodierendes nukleinsäuremolekül | |
EP1174522A3 (de) | Tcf-1 Nukleotidsequenzvariation | |
DE3851045D1 (de) | Träger für DNS-Hybridisierung. | |
BR9801379A (pt) | Processo de preparação de dinitroanilinas dissubstituidas em 3,4 | |
DE60238915D1 (de) | Werkzeug zur herstellung dekorativer muster auf einem beschichtungsmaterial | |
BR9901948B1 (pt) | processo de curtimento de couros com compostos carbonÍlicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1063294 Country of ref document: EP |